注目はＭＤＮＴ、悪性腫瘍による高カルシウム血症の治療薬として使用される

注目はＭＤＮＴ、悪性腫瘍による高カルシウム血症の治療薬として使用されるビスホスホネートを用いた樹状細胞を調製する技術に関し、ヨーロッパ・オーストラリア・韓国に続きアメリカでの特許が成立したと発表してます。
この技術は、ＭＤＮＴが提供している樹状細胞ワクチンの調製方法。樹状細胞にビスホスホネートの一種であるゾレドロン酸をパルスすることにより、
従来の方法に、比べ強力な樹状細胞を調製することができることになります。

結果 (英語) 1:

I am pleased to announce On technology for preparing dendritic cells using a bisphosphonate to be used for the treatment of hypercalcemia MDNT, by malignant tumors, patent in the United States has been established following the Europe, Australia and South Korea attention .
This technology is a process for the preparation of dendritic cell vaccine MDNT has to offer. By pulsing the zoledronic acid, which is a kind of bisphosphonates in dendritic cells, the method of
conventionalIt means that it is possible to prepare a strong dendritic cells compared.

結果 (英語) 2:

Attention regarding bisphosphonate that is used as a treatment of hypercalcemia by MDNT, malignant tumors with dendritic cell preparation technology and approved patents in the United States continued in Europe, Australia, and Korea are announced.
This technology is a method for preparation of dendritic cells vaccine supplied by MDNT. Dendritic cells by pulse of the bisphosphonate zoledronic acid
in the traditional wayPreparing dendritic cells compared with powerful that can be.

結果 (英語) 3:

The attention announces that a patent in U.S.A. was formed following Europe Australia / Korea about technology to prepare a dendritic cell with bisphosphonate used as MDNT, a therapeutic drug of the hypercalcaemia by the malignant tumor.
A preparation method of the dendritic cell vaccine that MDNT offers this technology. By doing a pulse of the zoledronic acid which is a kind of the bisphosphonate to a dendritic cell in a method of
before,I compare it and may prepare a strong dendritic cell.